Kevin Haigis Lab

Integrating Cancer Biology and Systems Biology to Identify New Therapeutic Opportunities, focusing on the RAS oncoproteins.

[Fusion Conferences @Fusion_Conf]

Drumroll please...🥁
Our February 2025 meetings are now LIVE on our website! We're super excited to be heading to a BRAND NEW location, the Dominican Republic! 🇩🇴
We have some amazing conferences scheduled, head to our conference website for more info➡️https://t.co/cf0erYiEQ9

[Dana-Farber News @DanaFarberNews]

Congrats Kevin Haigis, PhD, @DanaFarber's Chief Scientific Officer - recognized as a Fellow of the American Association for the Advancement of Science (@aaas) for distinguished contributions within biological sciences. @KevinHaigisLab

Press release: https://t.co/hL0Zct9ejE

[Fay Nicolson @NicolsonFay]

Hard launch! First week as a #NewPI @DanaFarber 👩‍🔬 Interested in molecular imaging, chemistry or radiobiology? Postdoc and research tech positions to follow soon! Eternally grateful to @KevinHaigisLab and the lab for their support over the last 3.5 years 🧬🧫🧪☢️⭐️🔬

[Anirban Maitra @Aiims1742]

In @CEBP_AACR
Effects of KRAS genetic interactions on outcomes in #LungCancer, #PancreaticCancer & #ColorectalCancer
https://t.co/uJjteaOJYX
Mining the massive @AACR GENIE database, this study identifies the prognostic impact of KRAS mutations on survival (across all three cancers, harboring a KRAS mutation has a deleterious impact on survival versus wild type alleles), although there are clear specific effects of individual variants. @KevinHaigisLab @KenLauLab @skopetz

[Dana-Farber Cancer Biology Department @DFCI_CancerBio]

A new leader of @NIH! Congratulations Dr. Bertagnolli!

[Cancer Research @CR_AACR]

From the newest issue— Allosteric Regulation of Switch-II Domain Controls #KRAS Oncogenicity, by @simanshu, @FredNatLab, @KevinHaigisLab et al.
https://t.co/vM1YLHODvZ
@DanaFarberNews

[National Cancer Institute @theNCI]

NEW! On the RAS Dialogue Blog, Drs. Olesja Popow and Kevin Haigis share their insights into the persistent question of why #KRAS mutations drive cancers in some tissues and not in others. https://t.co/CsaVNoXyYG

[Kevin Haigis Lab @KevinHaigisLab]

A special thank you to Clint Stalnecker and Channing Der @derlabunc for writing an excellent preview for our Molecular Cell paper out this week.
https://t.co/QOyXV5Yu76

[Fusion Conferences @Fusion_Conf]

Next up, our very own conference chair @KevinHaigisLab takes the stage with a talk on TISSUE-SPECIFIC ONCOGENICITY OF K-RAS #AMC23

[Julien Sage @SageJulien]

⁦@KevinHaigisLab⁩ opening remarks for the first Fusion conference ⁦@Fusion_Conf⁩ on animal models of cancer #AMC23

[Fusion Conferences @Fusion_Conf]

What a group! Some fantastic research shared so far, and even more to come, including our Poster Session, Gala Dinner and a Wine Tour at a local vineyard🐭🍷 #AMC23

[Kevin Haigis Lab @KevinHaigisLab]

Congratulations to the newly minted Dr. Bing Shui on his paper describing the global regulation of miRNA function by oncogenic K-Ras. Another piece of the puzzle.
https://t.co/xhvG9NnCt3

[Cancer Discovery @CD_AACR]

Check out the Cancer Discovery papers highlighted in the new @AACR Journals collection, Targeting KRAS.
https://t.co/4WuppSt9Mi
@norbertkraut1 @KevinHaigisLab @AnnaFaragoMD

[Dana-Farber News @DanaFarberNews]

What's to blame for certain cancer outcomes? A pair of studies shows the Y chromosome plays a key role in colon and bladder cancers. @DanaFarber's Chief Scientific Officer Kevin Haigis (@KevinHaigisLab) talks with @USATODAY about the findings:

https://t.co/8EwlGFAbML

[Fusion Conferences @Fusion_Conf]

Don't forget to register before Friday! #AMC23 is shaping up to be a fantastic meeting, with an incredible line up of speakers & opportunities for poster presentation across the programme.
📌Poster submission: 19 May 2023
📆Registration: 19 May 2023
🌐https://t.co/8PQpQpV1jw

[Andrea Ventura @aventura71]

We are recruiting a research tech with some experience in handling a mouse colony. Location: MSKCC, Manhattan. Competitive pay and benefits. Email: [email protected] if interested. Please RT

[The Jimmy Fund @TheJimmyFund]

Register today for @DanaFarber’s CSO Forum on 3/28 to learn how scientific collaborations with researchers and physicians worldwide help advance revolutionary science and extraordinary care for patients with cancer.

Sign-up today for this virtual event: https://t.co/kQPDsedUmu

[Tali Lev @TaliLev123]

🌟At #AACRras23: @KevinHaigisLab speaks about K-RAS hyperexchange mutants in colorectal cancer. See his Review article published in @CD_AACR last year: Classification of KRAS-Activating Mutations and the Implications for Therapeutic Intervention 👇
https://t.co/gsJ74YtoLZ

[Tali Lev @TaliLev123]

🌟🌟🌟@KevinHaigisLab speaks today at #AACRras23. Find his review about Classification of KRAS-Activating Mutations and the Implications for Therapeutic Intervention published last year in @CD_AACR for the 40 years anniversary 👇
https://t.co/gsJ74YtoLZ

[Fusion Conferences @Fusion_Conf]

Deadline Extended!
There's just one more week to secure discounted registration & submit an abstract for talk consideration at #AMC23. With an incredible speaker line up, this is not one to miss!
📆Talk submission: 03 Mar 2023
🌐https://t.co/8PQpQpV1jw @KevinHaigisLab @SageJulien